![David Rodman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Rodman
Chief Tech/Sci/R&D Officer at
MINERALYS THERAPEUTICS, INC.
Net worth: 2 M $ as of 31/05/2026
Profile
David M.
Rodman is currently a Member-Editorial Board at American Thoracic Society, Inc. and Chief Medical Officer at Mineralys Therapeutics, Inc. since 2021.
Former roles include Vice President-Clinical Development at Vertex Pharmaceuticals, Inc. from 2011 to 2014; Executive Vice President-Research & Development at miRagen Therapeutics, Inc.; Professor at The University of Colorado; Head-Respiratory Translational Medicine at Novartis Institutes for Biomedical Research, Inc.; Chief Medical Officer & Executive VP-Discovery at Nivalis Therapeutics, Inc. from 2016 to 2017; and Executive Vice President-Research & Development at ProQR Therapeutics NV.
Education includes a doctorate from the University of Pennsylvania in 1980 and an undergraduate degree from Haverford College in 1976.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/06/2026 | 57,095 ( 0.08% ) | 2 M $ | 31/05/2026 |
David Rodman active positions
| Companies | Position | Start |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2021 |
American Thoracic Society, Inc.
 American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services Profession membership organization for thoracic surgeons. | Corporate Officer/Principal | - |
Former positions of David Rodman
| Companies | Position | End |
|---|---|---|
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Chief Tech/Sci/R&D Officer | 15/01/2017 |
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Tech/Sci/R&D Officer | 01/04/2014 |
| PROQR THERAPEUTICS N.V. | Chief Tech/Sci/R&D Officer | - |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | - |
Training of David Rodman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
miRagen Therapeutics, Inc. /Old/
 miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops microRNA-based therapeutics for cardiovascular and muscle diseases | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Haverford College
 Haverford College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
American Thoracic Society, Inc.
American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services Profession membership organization for thoracic surgeons. | Commercial Services |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Health Technology |
ProQR Therapeutics NV
 ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Mineralys Therapeutics, Inc.
 Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases | Health Technology |
- Stock Market
- Insiders
- David Rodman
